241
TITLE: TRPV1: a therapeutic target for novel analgesic drugs?  Full Text
AUTHORS: Szallasi, A; Cruz, F ; Geppetti, P;
PUBLISHED: 2006, SOURCE: TRENDS IN MOLECULAR MEDICINE, VOLUME: 12, ISSUE: 11
INDEXED IN: Scopus WOS CrossRef: 144
IN MY: ORCID
243
TITLE: Inhibition of ERK phosphorylation decreases nociceptive behaviour in monoarthritic rats  Full Text
AUTHORS: Cruz, CD ; Neto, F.L. ; Castro Lopes, J ; McMahon, SB; Cruz, F ;
PUBLISHED: 2005, SOURCE: PAIN, VOLUME: 116, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef: 66
IN MY: ORCID
244
TITLE: The distribution of sensory fibers immunoreactive for the TRPV1 (capsaicin) receptor in the human prostate  Full Text
AUTHORS: Dinis P, Dinis-Oliveira P, Dinis Oliveira P, Oliveira PD, ; Charrua, A ; Avelino, A ; Nagy, I; Quintas, J; Ribau, U; Cruz, F ;
PUBLISHED: 2005, SOURCE: EUROPEAN UROLOGY, VOLUME: 48, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 50
IN MY: ORCID
245
TITLE: TRPV1 agonist therapies in bladder diseases
AUTHORS: Francisco Cruz ; Carlos Silva ; Dinis P, Dinis-Oliveira P, Dinis Oliveira P, Oliveira PD, ;
PUBLISHED: 2005, SOURCE: Turning up the Heat on Pain: TRPV1 Receptors in Pain and Inflammation - Progress in Inflammation Research
INDEXED IN: CrossRef: 1
IN MY: ORCID
249
TITLE: Botulinum toxin in the management of lower urinary tract dysfunction: contemporary update
AUTHORS: Cruz, F ; Silva, C ;
PUBLISHED: 2004, SOURCE: CURRENT OPINION IN UROLOGY, VOLUME: 14, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 23
IN MY: ORCID
Page 25 of 29. Total results: 285.